美国医院内发病与社区发病脓毒症的流行病学及死亡关联:基于电子临床数据的回顾性分析
该回顾性队列研究纳入2009-2015年美国136家医院的220万例成人住院患者,采用美国疾病控制与预防中心成人脓毒症事件标准识别脓毒症,比较医院内发病与社区发病脓毒症的流行病学特征及死亡风险。共识别95,154例脓毒症,其中医院内发病11,534例(12.1%),占住院队列的0.5%。医院内发病脓毒症患者更年轻但合并症更多、序贯器官衰竭评估评分更高、ICU入住率更高、住院时间更长、院内死亡率更高(33% vs 17%)。多因素分析显示,医院内发病脓毒症与社区发病脓毒症相比死亡风险升高(比值比2.1;95%CI 2.0-2.2),在入院时无脓毒症的患者中,医院内发病脓毒症使死亡风险增至3倍(风险比3.0;95%CI 2.9-3.2)。
要点
- 医院内发病脓毒症占全部脓毒症的12.1%(11,534/95,154),占住院队列的0.5%,即每200例住院中发生1例。
- 医院内发病脓毒症患者院内死亡率为33%,显著高于社区发病脓毒症的17%(p<0.001)。
- 经多因素调整后,医院内发病脓毒症死亡风险为社区发病脓毒症的2.1倍(OR 2.1;95%CI 2.0-2.2)。
- 在入院时无脓毒症的患者中,医院内发病脓毒症使死亡风险增至3倍(HR 3.0;95%CI 2.9-3.2)。
- 医院内发病脓毒症患者ICU入住率61%、中位住院时间19天,均高于社区发病脓毒症的44%和8天。
适用人群与场景
- 2009-2015年美国136家医院住院的成人患者,数据来源于Cerner HealthFacts数据集。
- 纳入分析的患者包括入院时即有社区发病脓毒症者,以及入院时无脓毒症但住院期间发生医院内发病脓毒症者。
诊断标准与关键阈值
- 采用美国疾病控制与预防中心成人脓毒症事件标准识别脓毒症。
- 脓毒症分为社区发病脓毒症与医院内发病脓毒症两类,共识别95,154例脓毒症病例。
研究设计与关键结果
- 回顾性队列研究,纳入220万例住院患者,共识别95,154例脓毒症:社区发病脓毒症83,620例(87.9%),医院内发病脓毒症11,534例(12.1%),医院内发病脓毒症占住院队列的0.5%。
- 与社区发病脓毒症相比,医院内发病脓毒症患者更年轻(中位年龄66岁 vs 68岁),但合并症更多(中位Elixhauser评分14 vs 11)、序贯器官衰竭评估评分更高(中位4 vs 3)、ICU入住率更高(61% vs 44%)、住院时间更长(中位19天 vs 8天)、院内死亡率更高(33% vs 17%),所有比较p<0.001。
- 多因素分析(调整基线特征与疾病严重程度)显示,医院内发病脓毒症与社区发病脓毒症相比死亡风险升高(比值比2.1;95%CI 2.0-2.2)。
- 在入院时无脓毒症的患者中,以脓毒症为时间依赖协变量的Cox回归模型显示,医院内发病脓毒症使死亡风险增至3倍(风险比3.0;95%CI 2.9-3.2)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 医院内发病脓毒症占脓毒症病例的八分之一,每200例住院中发生1例,每3例医院内发病脓毒症患者中1例死于院内,作者认为医院内发病脓毒症是监测、预防和质量改进的重要目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prior studies have reported that hospital-onset sepsis is associated with higher mortality rates than community-onset sepsis. Most studies, however, have used inconsistent case-finding methods and applied limited risk-adjustment for potential confounders. We used consistent sepsis criteria and detailed electronic clinical data to elucidate the epidemiology and mortality associated with hospital-onset sepsis.
DESIGN: Retrospective cohort study.
SETTING: 136 U.S. hospitals in the Cerner HealthFacts dataset.
PATIENTS: Adults hospitalized in 2009-2015.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We identified sepsis using Centers for Disease Control and Prevention Adult Sepsis Event criteria and estimated the risk of in-hospital death for hospital-onset sepsis versus community-onset sepsis using logistic regression models. In patients admitted without community-onset sepsis, we estimated risk of death associated with hospital-onset sepsis using Cox regression models with sepsis as a time-varying covariate. Models were adjusted for baseline characteristics and severity of illness. Among 2.2 million hospitalizations, there were 95,154 sepsis cases: 83,620 (87.9%) community-onset sepsis and 11,534 (12.1%) hospital-onset sepsis (0.5% of hospitalized cohort). Compared to community-onset sepsis, hospital-onset sepsis patients were younger (median 66 vs 68 yr) but had more comorbidities (median Elixhauser score 14 vs 11), higher Sequential Organ Failure Assessment scores (median 4 vs 3), higher ICU admission rates (61% vs 44%), longer hospital length of stay (median 19 vs 8 d), and higher in-hospital mortality (33% vs 17%) (p < 0.001 for all comparisons). On multivariate analysis, hospital-onset sepsis was associated with higher mortality versus community-onset sepsis (odds ratio, 2.1; 95% CI, 2.0-2.2) and patients admitted without sepsis (hazard ratio, 3.0; 95% CI, 2.9-3.2).
CONCLUSIONS: Hospital-onset sepsis complicated one in 200 hospitalizations and accounted for one in eight sepsis cases, with one in three patients dying in-hospital. Hospital-onset sepsis preferentially afflicted ill patients but even after risk-adjustment, they were twice as likely to die as community-onset sepsis patients; in patients admitted without sepsis, hospital-onset sepsis tripled the risk of death. Hospital-onset sepsis is an important target for surveillance, prevention, and quality improvement initiatives.
参考来源
- Rhee C, Wang R, Zhang Z, et al. Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data. Crit Care Med. 2019. PMID: 31135503. doi:10.1097/CCM.0000000000003817
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。